focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Annual Report and Accounts

20 Apr 2012 09:15

RNS Number : 7436B
Cathay International Holdings Ld
20 April 2012
 



Cathay International Holdings Limited

("Cathay" or the "Company")

 

Annual Report and Accounts

 

Hong Kong, 20 April 2012 - Cathay International Holdings Ltd. (LSE: CTI.L), an investment holding company and a leading investor in the growing healthcare sector in the People's Republic of China, today announces that that its Annual Report and Accounts for the financial year ended 31 December 2011 together with the Notice of Annual General Meeting ("AGM") and Form of Proxy for its forthcoming AGM have been posted to shareholders. These documents will also be uploaded to National Storage Mechanism. An electronic copy of the Annual Report and Accounts is also now available on the Company's website at http://www.cathay-intl.com.hk and printed copies are available upon request.

 

- ENDS -

 

For further enquiries, please contact:

 

Cathay International Holdings Limited

Eric Siu (Finance Director)

Patrick Sung (Director and Controller)

 

Tel: +852 2828 9289

 

M:Communications

Mary-Jane Elliott / Amber Bielecka / Claire Dickinson

 

 

Tel: +44 (0)20 7920 2330

 

About Cathay

Cathay International Holdings Limited (CTI.L), focused on the People's Republic of China ("PRC"), is an investment holding company and a leading investor in the growing healthcare sector in China. The Group employs more than 2,000 people across the PRC, including over 30 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen.

 

Cathay aims to identify investment opportunities with emphasis on high growth healthcare markets and build them into market sector leaders, with a clear exit strategy. Cathay has demonstrated a strong track record of identifying high-growth potential investment opportunities in this area including: Lansen Group, a leading specialty pharmaceutical company focused on rheumatology and Haotian Group, a company engaged in the manufacture, marketing and sale of key active ingredients for healthcare products, including inositol. To complement its healthcare portfolio, Cathay has an R&D business focused on bringing new products to the growing Chinese market.

 

Cathay also has a private equity investment arm focused on minority investment opportunities and a hotel investment.

 

The Company's website is at http://www.cathay-intl.com.hk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACSSESSASFESEFL

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.